249 related articles for article (PubMed ID: 22563476)
1. JNK3 maintains expression of the insulin receptor substrate 2 (IRS2) in insulin-secreting cells: functional consequences for insulin signaling.
Abdelli S; Bonny C
PLoS One; 2012; 7(5):e35997. PubMed ID: 22563476
[TBL] [Abstract][Full Text] [Related]
2. JNK1 Deficient Insulin-Producing Cells Are Protected against Interleukin-1β-Induced Apoptosis Associated with Abrogated Myc Expression.
Prause M; Mayer CM; Brorsson C; Frederiksen KS; Billestrup N; Størling J; Mandrup-Poulsen T
J Diabetes Res; 2016; 2016():1312705. PubMed ID: 26962537
[TBL] [Abstract][Full Text] [Related]
3. JNK3 is abundant in insulin-secreting cells and protects against cytokine-induced apoptosis.
Abdelli S; Puyal J; Bielmann C; Buchillier V; Abderrahmani A; Clarke PG; Beckmann JS; Bonny C
Diabetologia; 2009 Sep; 52(9):1871-80. PubMed ID: 19609503
[TBL] [Abstract][Full Text] [Related]
4. JNK1 protects against glucolipotoxicity-mediated beta-cell apoptosis.
Prause M; Christensen DP; Billestrup N; Mandrup-Poulsen T
PLoS One; 2014; 9(1):e87067. PubMed ID: 24475223
[TBL] [Abstract][Full Text] [Related]
5. JNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated multidrug resistance of hepatocellular carcinoma cells.
Yan F; Wang XM; Liu ZC; Pan C; Yuan SB; Ma QM
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):287-95. PubMed ID: 20525557
[TBL] [Abstract][Full Text] [Related]
6. Forkhead box O1/pancreatic and duodenal homeobox 1 intracellular translocation is regulated by c-Jun N-terminal kinase and involved in prostaglandin E2-induced pancreatic beta-cell dysfunction.
Meng Z; Lv J; Luo Y; Lin Y; Zhu Y; Nie J; Yang T; Sun Y; Han X
Endocrinology; 2009 Dec; 150(12):5284-93. PubMed ID: 19837872
[TBL] [Abstract][Full Text] [Related]
7. Isoform-specific functions of c-Jun N-terminal kinase 1 and 2 in lung ischemia-reperfusion injury through the c-Jun/activator protein-1 pathway.
Tan J; Gao W; Yang W; Zeng X; Wang L; Cui X
J Thorac Cardiovasc Surg; 2021 Aug; 162(2):e143-e156. PubMed ID: 32414595
[TBL] [Abstract][Full Text] [Related]
8. c-JUN N-terminal kinase-1 (JNK1) but not JNK2 or JNK3 is involved in UV signal transduction in human epidermis.
Katagiri C; Negishi K; Hibino T
J Dermatol Sci; 2006 Sep; 43(3):171-9. PubMed ID: 16824735
[TBL] [Abstract][Full Text] [Related]
9. Distinct roles of c-Jun N-terminal kinase isoforms in neurite initiation and elongation during axonal regeneration.
Barnat M; Enslen H; Propst F; Davis RJ; Soares S; Nothias F
J Neurosci; 2010 Jun; 30(23):7804-16. PubMed ID: 20534829
[TBL] [Abstract][Full Text] [Related]
10. The Map3k12 (Dlk)/JNK3 signaling pathway is required for pancreatic beta-cell proliferation during postnatal development.
Tenenbaum M; Plaisance V; Boutry R; Pawlowski V; Jacovetti C; Sanchez-Parra C; Ezanno H; Bourry J; Beeler N; Pasquetti G; Gmyr V; Dalle S; Kerr-Conte J; Pattou F; Hirai SI; Regazzi R; Bonnefond A; Froguel P; Abderrahmani A
Cell Mol Life Sci; 2021 Jan; 78(1):287-298. PubMed ID: 32189007
[TBL] [Abstract][Full Text] [Related]
11. SAPKgamma/JNK1 and SAPKalpha/JNK2 mRNA transcripts are expressed in early gestation human placenta and mouse eggs, preimplantation embryos, and trophoblast stem cells.
Zhong W; Sun T; Wang QT; Wang Y; Xie Y; Johnson A; Leach R; Puscheck EE; Rappolee DA
Fertil Steril; 2004 Oct; 82 Suppl 3():1140-8. PubMed ID: 15474087
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective Effects of the Absence of JNK1 or JNK3 Isoforms on Kainic Acid-Induced Temporal Lobe Epilepsy-Like Symptoms.
de Lemos L; Junyent F; Camins A; Castro-Torres RD; Folch J; Olloquequi J; Beas-Zarate C; Verdaguer E; Auladell C
Mol Neurobiol; 2018 May; 55(5):4437-4452. PubMed ID: 28664455
[TBL] [Abstract][Full Text] [Related]
13. Biological Properties of JNK3 and Its Function in Neurons, Astrocytes, Pancreatic β-Cells and Cardiovascular Cells.
Nakano R; Nakayama T; Sugiya H
Cells; 2020 Jul; 9(8):. PubMed ID: 32751228
[TBL] [Abstract][Full Text] [Related]
14. Arrestin-3 binds c-Jun N-terminal kinase 1 (JNK1) and JNK2 and facilitates the activation of these ubiquitous JNK isoforms in cells via scaffolding.
Kook S; Zhan X; Kaoud TS; Dalby KN; Gurevich VV; Gurevich EV
J Biol Chem; 2013 Dec; 288(52):37332-42. PubMed ID: 24257757
[TBL] [Abstract][Full Text] [Related]
15. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
Liu J; Minemoto Y; Lin A
Mol Cell Biol; 2004 Dec; 24(24):10844-56. PubMed ID: 15572687
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt.
Sunters A; Madureira PA; Pomeranz KM; Aubert M; Brosens JJ; Cook SJ; Burgering BM; Coombes RC; Lam EW
Cancer Res; 2006 Jan; 66(1):212-20. PubMed ID: 16397234
[TBL] [Abstract][Full Text] [Related]
17. Insulin signaling pathway protects neuronal cell lines by Sirt3 mediated IRS2 activation.
Mishra N; Lata S; Deshmukh P; Kamat K; Surolia A; Banerjee T
Biofactors; 2018 May; 44(3):224-236. PubMed ID: 29411439
[TBL] [Abstract][Full Text] [Related]
18. JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases.
Hu MC; Qiu WR; Wang YP
Oncogene; 1997 Nov; 15(19):2277-87. PubMed ID: 9393873
[TBL] [Abstract][Full Text] [Related]
19. A selective small-molecule inhibitor of c-Jun N-terminal kinase 1.
Yao K; Cho YY; Bode AM; Vummenthala A; Park JG; Liu K; Pang YP; Dong Z
FEBS Lett; 2009 Jul; 583(13):2208-12. PubMed ID: 19527717
[TBL] [Abstract][Full Text] [Related]
20. Glucose and fatty acids synergize to promote B-cell apoptosis through activation of glycogen synthase kinase 3β independent of JNK activation.
Tanabe K; Liu Y; Hasan SD; Martinez SC; Cras-Méneur C; Welling CM; Bernal-Mizrachi E; Tanizawa Y; Rhodes CJ; Zmuda E; Hai T; Abumrad NA; Permutt MA
PLoS One; 2011 Apr; 6(4):e18146. PubMed ID: 21541314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
